advertisement
Kopczynski C 7
Showing records 1 to 7 | Display all abstracts from Kopczynski C107452 Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates
Sturdivant J
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 117-127
107694 Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes
Ren R
Investigative Ophthalmology and Visual Science 2023; 64: 7
107452 Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates
Williams SS
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 117-127
107694 Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes
Humphrey AA; Kopczynski C
Investigative Ophthalmology and Visual Science 2023; 64: 7
107452 Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates
Ina M
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 117-127
107694 Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes
Gong H
Investigative Ophthalmology and Visual Science 2023; 64: 7
107452 Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates
Weksler M; McDougal A; Clancy D; deLong MA; Girouard N; Zaretskaia M; Brennan K; Glendenning A; Foley B; Lin CW; White JC; Kopczynski C; Kelly CR
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 117-127
